Harnessing Real-World Data to Inform Decision-Making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS)
Ellen M. Mowry(Johns Hopkins University), Richard A. Rudick(Icahn School of Medicine at Mount Sinai), Jacqueline Nicholas(OhioHealth), Björn Tackenberg(Universitätsklinikum Gießen und Marburg), Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya), James R. Williams(Biogen (United States)), Yvonne W. Lui(New York University), Mar Tintoré(Vall d'Hebron Hospital Universitari), Hagen H. Kitzler(TU Dresden), Madalina E. Tivarus(University of Rochester), Àlex Rovira(Centre National de la Recherche Scientifique), Robert T. Naismith(Washington University in St. Louis), Carl de Moor(Biogen (United States)), Stephen E. Jones(UCSF Helen Diller Family Comprehensive Cancer Center), Carrie M. Hersh(Cleveland Clinic), Izlem Izbudak, Fabio Pellegrini(Biogen (Switzerland)), Megan Hyland(University of Rochester Medical Center), Elizabeth Fisher(Novartis (United States)), Maximilian Schulze(Universitätsklinikum Gießen und Marburg), Bernd C. Kieseier(Heinrich Heine University Düsseldorf), Robert Bermel(Cleveland Clinic), Tammie L.S. Benzinger(Washington University in St. Louis), Tjalf Ziemssen(University Hospital Carl Gustav Carus), Lauren Krupp(NYU Langone Health)
Cited by 91
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Palbociclib and Letrozole in Advanced Breast Cancer
|New England Journal of Medicine|2016|2.9k